Abstract
SUMMARyThe risk of transfusion‐transmitted viral infections is presently exceedingly low, and mathematical modeling is necessary to estimate the magnitude of the residual risk. Direct calculation of the risk from prospective studies of transfusion recipients is either not possible or prohibitively expensive. The accumulated experience with the incidence/window‐period model indicates that this approach can predict (1) the approximate residual risk of transfusion‐transmitted infections that are characterized by an infectious window period before appearance of infectious disease markers in peripheral blood; and (2) the approximate risk reduction that can be expected with implementation of new tests.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
